The research was designed to predict the relationship between the apnea-hypopnea index (AHI) as the main indicator of severity of obstructive sleep apnea syndrome (OSAS), and lipid panel test results. A cross-sectional observational study was done on 90 patients with suspected sleep-related breathing disorders as assumed by polysomnography. Patients were categorized into three equal groups depending on AHI: mild degree (5-15 events/hour), moderate degree (15-30 events/hour), and severe degree (> 30 events/hour). All patients underwent a comprehensive medical history, PSG, and lipid panel tests, which included measurements of total cholesterol level, low-density lipoprotein (LDL) level, very low-density lipoprotein (VLDL) level, high-density lipoprotein (HDL) level, and triglycerides (TGs) level. Aclose relation was noted between degree of severity of OSA and lipid panel tests that in third group (Severe degree) exhibited significantly higher levels of triglycerides (212 ± 36 mg/dL), total cholesterol (180 ± 54 mg/dL), and LDL (178.1 ± 39.8 mg/dL) compared to those with moderate (TGs: 158 ± 57 mg/dL, total cholesterol: 151 ± 65 mg/dL, LDL: 153.2 ± 31.5 mg/dL) and mild OSA (TGs: 106 ± 37 mg/dL, total cholesterol: 85 ± 12 mg/dL, LDL: 87 ± 9.3 mg/dL), with P-values < 0.001. Conversely, significantly lower level of HDLin the severe OSA group (25.8 ± 3.6 mg/dL) compared to moderate (32.7 ± 4.2 mg/dL) and mild OSA groups (45.8 ± 9.2 mg/dL), with a -value < 0.001. so analysis of Multivariate linear regression unveiled that both moderate and severe OSA stood as independent predictors for elevated TC, TGs, and LDL levels, alongside diminished HDL levels, according to age, sex, and BMI. Oxygen desaturation due to OSA significantly impacts lipid metabolism, leading to dyslipidemia and increased cardiovascular risk.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11890882 | PMC |
http://dx.doi.org/10.1007/s12070-024-05178-6 | DOI Listing |
Indian J Otolaryngol Head Neck Surg
January 2025
Otorhinolaryngology Department, Faculty of Medicine, Benha University, Benha, 13511 Qalyubia Egypt.
The research was designed to predict the relationship between the apnea-hypopnea index (AHI) as the main indicator of severity of obstructive sleep apnea syndrome (OSAS), and lipid panel test results. A cross-sectional observational study was done on 90 patients with suspected sleep-related breathing disorders as assumed by polysomnography. Patients were categorized into three equal groups depending on AHI: mild degree (5-15 events/hour), moderate degree (15-30 events/hour), and severe degree (> 30 events/hour).
View Article and Find Full Text PDFSci Rep
March 2025
Cancer Research Program, Research Institute of the McGill University Health Centre, 1001 Decarie Blvd, Montreal, QC, H4A 3J1, Canada.
Extracellular vesicles (EVs) are secreted by most cell types and play a central role in cell-cell communication. These naturally occurring nanoparticles have been particularly implicated in cancer, but EV heterogeneity and lengthy isolation methods with low yield make them difficult to study. To circumvent the challenges in EV research, we aimed to develop a unique synthetic model by engineering bioinspired liposomes to study EV properties and their impact on cellular uptake.
View Article and Find Full Text PDFMetabolomics
March 2025
Department of Digestive and Hepatobiliary Medicine, CHU Clermont-Ferrand, Clermont-Ferrand, F-63000, France.
Introduction: Metabolic steatotic liver disease (MASLD) can progress to hepatocellular carcinoma (HCC). 25% of MASLD-HCCs occur in the absence of fibrosis.
Objectives: This study aimed to explore lipid metabolic pathways through "omics" and to identify biomarkers of MASLD-HCC based on the degree of fibrosis.
Cureus
February 2025
Rheumatology, Virginia Commonwealth University School of Medicine, Richmond, USA.
Objectives: Hepatotoxicity is a frequent reason why disease-modifying anti-rheumatic drugs (DMARDs) are stopped or changed. We hypothesize that features of metabolic syndrome (such as obesity, dyslipidemia, and diabetes) are risk factors for hepatotoxicity leading to DMARD change in rheumatoid arthritis (RA).
Methods: We conducted a retrospective chart review of 361 patients with RA.
Climacteric
March 2025
Department of Epidemiology, School of Public Health, Chongqing Medical University, Chongqing, China.
Objective: The concurrent presence of multiple chronic diseases, termed multimorbidity, is increasingly prevalent among patients with chronic illnesses. This phenomenon is particularly pronounced in middle-aged women, yet has not received adequate attention. The objective of this study was to investigate the pattern of multimorbidity and its changes over time in perimenopausal women.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!